Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function.

[1]  H. Kuypers,et al.  The paraventricular nucleus of the hypothalamus: Cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double‐labeling methods , 1980, The Journal of comparative neurology.

[2]  G. Unabia,et al.  Rapid corticosterone inhibition of corticotropin-releasing hormone binding and adrenocorticotropin release by enriched populations of corticotropes: counteractions by arginine vasopressin and its second messengers. , 1990, Endocrinology.

[3]  G. Chrousos,et al.  Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. , 1990, Endocrinology.

[4]  J. Nurnberger,et al.  Blunted ACTH and cortisol response to afternoon tryptophan infusion in euthymic bipolar patients , 1990, Psychiatry Research.

[5]  S. Garattini,et al.  From Fenfluramine Racemate to d‐Fenfluramine , 1987 .

[6]  T. Dinan,et al.  Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. , 1991, The American journal of psychiatry.

[7]  H. Westenberg,et al.  Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder , 1990, Psychiatry Research.

[8]  R. Kahn,et al.  The MCPP challenge test in schizophrenia: Hormonal and behavioral responses , 1991, Biological Psychiatry.

[9]  H. Meltzer,et al.  Neuroendocrine responses to serotonergic agents in alcoholics , 1991, Biological Psychiatry.

[10]  T F Gallagher,et al.  Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. , 1971, The Journal of clinical endocrinology and metabolism.

[11]  P. Munson,et al.  Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami , 1989, Peptides.

[12]  F. Holsboer,et al.  ACTH, cortisol, and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery , 1985, Biological Psychiatry.

[13]  R. Kahn,et al.  Serotonin receptor sensitivity in major depression , 1990, Biological Psychiatry.

[14]  D. Murphy,et al.  Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled study. , 1989, Archives of general psychiatry.

[15]  R. Donald.  REVIEW ARTICLE: ACTH AND RELATED PEPTIDES , 1980, Clinical endocrinology.

[16]  William Francis Ganong,et al.  Review of Medical Physiology , 1969 .

[17]  U. Knigge,et al.  Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan. , 1992, Neuroendocrinology.

[18]  P. Mitchell,et al.  Hormonal responses to fenfluramine in depressed and control subjects. , 1990, Journal of affective disorders.

[19]  R. Williams,et al.  Williams Textbook of endocrinology , 1985 .

[20]  B. McEwen,et al.  Rat Brain Binds Adrenal Steroid Hormone: Radioautography of Hippocampus with Corticosterone , 1972, Science.

[21]  J. Turk.  The Fragile-X Syndrome , 1992, British Journal of Psychiatry.

[22]  J. Burrin,et al.  Glycoprotein hormone alpha-subunit production and plurihormonality in human corticotroph tumours--an in vitro and immunohistochemical study. , 1995, European journal of endocrinology.

[23]  M. Apfelbaum.  Effect of serotonin on the basal and gonadotrophin-releasing hormone-induced release of luteinizing hormone from rat pituitary glands in vitro. , 1987, Life sciences.

[24]  H. Westenberg,et al.  Postsynaptic serotonergic activity in depressive patients: Evaluation of the neuroendocrine strategy , 1982, Psychiatry Research.

[25]  B. Flerkó.  The Hypophysial Portal Circulation Today , 1980 .

[26]  G. Kovacs,et al.  Aldosterone blocks the response to corticosterone in the raphe-hippocampal serotonin system , 1983, Brain Research.

[27]  S. Jeffcoate,et al.  The Endocrine hypothalamus , 1978 .

[28]  W. Rossmanith,et al.  Serotoninergic control of gonadotrophin and prolactin secretion in women , 1994, Clinical endocrinology.

[29]  G. Telegdy,et al.  Decreased serotonin turnover in the dorsal hippocampus of rat brain shortly after adrenalectomy: selective normalization after corticosterone substitution , 1982, Brain Research.

[30]  E. Azmitia,et al.  Specific in vitro uptake of serotonin by cells in the anterior pituitary of the rat. , 1982, Endocrinology.

[31]  V. Randall,et al.  In-vivo uptake and metabolism of testosterone by the skin and other tissues of the rat. , 1982, The Journal of endocrinology.

[32]  D. Charney,et al.  Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. , 1984, Archives of general psychiatry.

[33]  D. Hoyer,et al.  A proposed new nomenclature for 5-HT receptors. , 1993, Trends in pharmacological sciences.

[34]  E. D. de Kloet,et al.  Selective control by corticosterone of serotonin1 receptor capacity in raphe-hippocampal system. , 1986, Neuroendocrinology.

[35]  S. Shibahara,et al.  Isolation and sequence analysis of the human corticotropin‐releasing factor precursor gene. , 1983, The EMBO journal.

[36]  J. Martin,et al.  Neural regulation of growth hormone secretion. , 1973, The Medical clinics of North America.

[37]  R. Alper.  Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat. , 1990, Neuroendocrinology.

[38]  I. Clarke,et al.  Glucocorticoids regulate ovine hypophysial portal levels of corticotropin-releasing factor and arginine vasopressin in a stress-specific manner. , 1989, Endocrinology.

[39]  D. Murphy,et al.  β-Endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action , 1990, Brain Research.

[40]  T. Dinan,et al.  Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression , 1995, Biological Psychiatry.

[41]  R. Kahn,et al.  Hormonal probes of central serotonergic activity: Do they really exist? , 1987, Biological Psychiatry.

[42]  B. Carroll.  The Dexamethasone Suppression Test for Melancholia , 1982, British Journal of Psychiatry.

[43]  H. Kawano,et al.  CRF‐containing neuron systems in the rat hypothalamus: Retrograde tracing and immunohistochemical studies , 1988, The Journal of comparative neurology.

[44]  H. Meltzer,et al.  Hormone response to 5-HTP , 1983, Psychiatry Research.

[45]  M. Maes,et al.  HPA-Axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls , 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[46]  H. Meltzer,et al.  Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects , 1994, Biological Psychiatry.

[47]  A. Grossman,et al.  Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro. , 1989, Endocrinology.

[48]  M. Sole,et al.  Decreased brain serotonin turnover after short term (two-hour) adrenalectomy in rats: a comparison of four turnover methods. , 1981, Endocrinology.

[49]  P. Sawchenko,et al.  Widespread expression of corticotropin-releasing factor messenger RNA and immunoreactivity in the rat olfactory bulb , 1989, Brain Research.

[50]  L. Yatham,et al.  Neuroendocrine probes of serotonergic function: a critical review. , 1993, Life sciences.

[51]  H. Imura,et al.  Effect of 5-hydroxytryptophan (5-HTP) on growth hormone and ACTH release in man. , 1973, The Journal of clinical endocrinology and metabolism.

[52]  W. Vale,et al.  Augmentation of ACTH-releasing activity of synthetic corticotropin releasing factor (CRF) by vasopressin in women. , 1983, The Journal of clinical endocrinology and metabolism.

[53]  M. Laraia,et al.  Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind trial. , 1995, The American journal of psychiatry.

[54]  A. Grossman,et al.  The regulation of hypothalamic CRH: impact of in vitro studies on the central control of the stress response. , 1993, Functional neurology.

[55]  J. Amsterdam,et al.  Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: A pilot study , 1987, Psychiatry Research.

[56]  B. Brodie,et al.  APPLICATION OF STEADY STATE KINETICS TO THE SYNTHESIS RATE AND TURNOVER TIME OF SEROTONIN IN THE BRAIN OF NORMAL AND RESERPINE-TREATED RATS , 1966 .

[57]  D. Wong,et al.  Serotonin Uptake and Serotonin Uptake Inhibition , 1990, Annals of the New York Academy of Sciences.

[58]  G. Klerman,et al.  The dexamethasone suppression test: An overview of its current status in psychiatry , 1987 .

[59]  F. Antoni,et al.  Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. , 1986, Endocrine reviews.

[60]  K. Lesch,et al.  Corticotropin and cortisol secretion after central 5-hydroxytryptamine-1A (5-HT1A) receptor activation: effects of 5-HT receptor and beta-adrenoceptor antagonists. , 1990, The Journal of clinical endocrinology and metabolism.

[61]  D. Murphy,et al.  Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans. , 1985, The Journal of clinical endocrinology and metabolism.

[62]  B. Sherman,et al.  Serotonergic stimulation of adrenocorticotropin secretion in man. , 1984, The Journal of clinical endocrinology and metabolism.

[63]  M. Wiesmann,et al.  5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls. , 1991, Archives of general psychiatry.

[64]  A. Coppen,et al.  5-hydroxytryptamine in psychiatry : a spectrum of ideas , 1991 .

[65]  G. Bagdy,et al.  Role for serotonin3 receptors in the control of adrenocorticotropic hormone release from rat pituitary cell cultures. , 1995, European journal of endocrinology.

[66]  E. Souza.  Serotonin and Dopamine Receptors in the Rat Pituitary Gland: Autoradiographic Identification, Characterization, and Localization* , 1986 .

[67]  E. Hollander,et al.  Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. , 1992, Archives of general psychiatry.

[68]  B. Donovan.  Third Geoffrey Harris Memorial Lecture. The portal vessels, the hypothalamus and the control of reproductive function. , 1978, Neuroendocrinology.

[69]  J. Simpkins,et al.  Serotonergic control of prolactin release in male rats. , 1979, Life sciences.

[70]  J. Clements,et al.  Glucocorticoid and mineralocorticoid effects on adrenocorticotropin and beta-endorphin in the adrenalectomized rat. , 1982, The Journal of clinical investigation.

[71]  R. Wurtman,et al.  Pituitary Serotonin Content: Effects of Melatonin or Deprivation of Water , 1970, Science.

[72]  G. Fink,et al.  Atrial Natriuretic Factor is Released into Hypophysial Portal Blood: Direct Evidence that Atrial Natriuretic Factor may be a Neurohormone Involved in Hypothalamic Pituitary Control , 1990, Journal of neuroendocrinology.

[73]  M. Palkovits,et al.  Immunoreactive corticotropin-releasing hormone in the hypothalamoinfundibular tract. , 1983, Neuroendocrinology.

[74]  O. Kletzky,et al.  Influence of sequential doses of 5-hydroxytryptophan on prolactin release. , 1986, American journal of obstetrics and gynecology.

[75]  B. McEwen,et al.  Adrenal steroid receptors and actions in the nervous system. , 1986, Physiological reviews.

[76]  L. Konopka,et al.  Serotonin-induced changes in membrane potential and cytosolic free calcium in a clonal pituitary cell line (AtT-20) of cultured mouse corticotropes. , 1994, Life sciences.

[77]  T. Dinan,et al.  Effect of metyrapone on the pituitary-adrenal axis in depression: relation to dexamethasone suppressor status. , 1992, Neuroendocrinology.

[78]  S. Peroutka,et al.  1-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain , 1989, Biological Psychiatry.

[79]  C. Johnston,et al.  Atrial natriuretic peptide is a physiological inhibitor of ACTH release: evidence from immunoneutralization in vivo. , 1991, The Journal of endocrinology.

[80]  A. Negro-Vilar,et al.  Serotonin and adrenocorticotropin (ACTH) release: direct effects at the anterior pituitary level and potentiation of arginine vasopressin-induced ACTH release. , 1983, Endocrinology.

[81]  M. Hyyppä,et al.  l-Tryptophan treatment and the episodic secretion of pituitary hormones and cortisol , 1979, Psychoneuroendocrinology.

[82]  F. Petraglia,et al.  Ritanserin, a Serotonin-S2 Receptor Antagonist, Does Not Prevent 5-Hydroxytryptophan-Induced β-EP, β-LPH and Cortisol Secretion , 1987 .

[83]  K. Lesch,et al.  Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans , 1989, Biological Psychiatry.

[84]  R. Sapolsky,et al.  Glucocorticoid feedback inhibition of adrenocorticotropic hormone secretagogue release. Relationship to corticosteroid receptor occupancy in various limbic sites. , 1990, Neuroendocrinology.

[85]  R. Balon,et al.  Effects of isoproterenol in panic disorder patients after antidepressant treatment , 1990, Biological Psychiatry.

[86]  D. Murphy,et al.  A preliminary study of the effects of intravenous m-chlorophenylpiperazine, a serotonin agonist, in elderly subjects , 1989, Biological Psychiatry.

[87]  R. Modlinger,et al.  Stimulation of aldosterone, renin, and cortisol by tryptophan. , 1979, The Journal of clinical endocrinology and metabolism.

[88]  P. Woolf,et al.  Effect of the serotonin precursor, tryptophan, on pituitary hormone secretion. , 1977, The Journal of clinical endocrinology and metabolism.

[89]  M. Palkovits,et al.  DISTRIBUTION OF BIOGENIC AMINES AND RELATED ENZYMES IN THE RAT PITUITARY GLAND , 1975, Journal of neurochemistry.

[90]  S. Woods,et al.  Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. , 1988, Archives of general psychiatry.

[91]  P. Blockx,et al.  Sex‐linked differences in cortisol, ACTH and prolactin responses to 5‐hydroxy‐tryptophan in healthy controls and minor and major depressed patients , 1989, Acta psychiatrica Scandinavica.

[92]  M. Dallman,et al.  Corticosteroid inhibition of ACTH secretion. , 1984, Endocrine reviews.

[93]  M. Feuilloley,et al.  Serotonin-induced stimulation of cortisol secretion from human adrenocortical tissue is mediated through activation of a serotonin4 receptor subtype , 1992, Neuroscience.

[94]  T. Wehr,et al.  Neuroendocrine response to 5-hydroxytryptophan in seasonal affective disorder. , 1987, Archives of general psychiatry.

[95]  Andrew H. Miller,et al.  The neuroendocrine response to fenfluramine in depressives and normal controls , 1988, Biological Psychiatry.

[96]  D. Murphy,et al.  Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjects , 1989, Psychiatry Research.

[97]  D. Murphy,et al.  Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. , 1984, Life sciences.

[98]  D. Fukushima,et al.  Cortisol production in depressive illness. A clinical and biochemical clarification. , 1970, Archives of general psychiatry.

[99]  T. Dinan.  Glucocorticoids and the Genesis of Depressive Illness a Psychobiological Model , 1994, British Journal of Psychiatry.

[100]  F. Holsboer,et al.  Circadian changes in the sensitivity of the corticotropin-releasing hormones-stimulated HPA system after arginine vasopressin and atrial natriuretic hormone in human male controls , 1995, Psychoneuroendocrinology.